O-GlcNAcylation-mediated glycolytic reprogramming of CD4+ T cells contributes to type H vessel impairment in diabetic osteoporosis
Authors:
- Hongrui LiuHLHongrui Liu
- Tomoka HasegawaTHTomoka Hasegawa
- Minqi LiMinqi Li
- 26 June 2026
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 146, 112694
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Taishan Scholar Foundation of Shandong Province
This publication has 54 references indexed in Scilit:
- Protein O‐GlcNAcylation in Health and DiseasesMedcomm, 2025
- Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3+ Tregs and CD8+ T cellsDiabetologia, 2025
- Hyperglycemia-triggered lipid peroxidation destabilizes STAT4 and impairs anti-viral Th1 responses in type 2 diabetesCell Metabolism, 2024
- Eldecalcitol ameliorates diabetic osteoporosis and glucolipid metabolic disorder by promoting Treg cell differentiation through SOCECellular and Molecular Life Sciences, 2024
- O-GlcNAcylation in cancer development and immunotherapyCancer Letters, 2023
- Contribution of Type H Blood Vessels to Pathologic Osteogenesis and Inflammation in an Experimental Spondyloarthritis ModelArthritis & Rheumatology, 2023
- The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogrammingCell Metabolism, 2022
- Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated InflammationCell Metabolism, 2020
- From Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular SenescenceCell Metabolism, 2016
- Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory PhenotypeCell Metabolism, 2016